ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2315

The Effectiveness of Social Media in Recruiting for Rare Rheumatic Diseases

Adam Schiffenbauer1, Lisa G. Rider2, Sara Faghihi-Kashani3, Komal Patel4 and Frederick W. Miller5, 1Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, 2Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, 3Environmental Autoimmunity Group, National Institute of Environmental Health, Bethesda, MD, 4Social and Scientific Systems, Inc., Bethesda, MD, 5Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, Bethesda, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: dermatomyositis, Myositis, polymyositis, recruitment and social media

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Muscle Biology, Myositis and Myopathies - Poster II: Clinical

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Clinical research is dependent on being able to recruit and enroll appropriate patients in sufficient numbers to make robust conclusions. For many diseases it can be difficult to obtain satisfactory numbers of participants, which can impact the quality of research performed. Investigators have used a variety of advertising methods to reach potential participants for research studies. Advertising through new technology platforms offers many advantages over other types of study advertising, particularly for rare diseases. By using these platforms, very specific groups of individuals can be targeted, thus increasing the probability that a person who sees a notice for a study has the disease being investigated. The idiopathic inflammatory myopathies are a group of rare muscle disorders and we performed advertising campaigns using Facebook and Google advertising platforms for these diseases in an attempt to evaluate their relative characteristics and effectiveness.

Methods:  IRB approval was obtained to use Facebook and Google advertising platforms for four NIH non-interventional studies attempting to enroll patients with juvenile or adult dermatomyositis, polymyositis, or inclusion body myositis. Targeted words and ad criteria were developed in conjunction with experts from each platform. Similar terms and criteria were picked for each platform. The advertising ran on Google from October 9th to November 18th 2015 and on Facebook from September 30th 2015 to February 17th 2016.

Results: Google ads had 1,285,733 views and Facebook ads had 335,941 views. In total, 0.54% of impressions on Google and 2.29% of impressions on Facebook led to a click of the advertisement. Google averaged about 80 cents a click and Facebook averaged 30 cents a click. Each site also collected additional advertising data about the population reached. On the Google platform 17 search terms led to 10 or more individuals clicking the advertisement and they were not the 17 terms with the highest number of impressions. With a list of 49 keywords there were 1110 distinct search terms used by end users that led to our advertisement being displayed. Facebook ads reached 191,098 individual people. The majority of individuals reached were female (175,914 female, 336 male, 127 unknown) and between the ages of 45-64 years (63% of the clicks and 55% of views). The vast majority of individuals seeing the Facebook ad did so on a mobile news feed (98% of all clicks and 97% of all views) with the rest viewing the ad on their desktop feed, third party mobile application or website, or desktop right hand column in order of frequency for views and clicks. Of the mobile devices used to access the content, 40% of clicks were on an android smartphone, 36% on an iPhone, 15% on an iPad, and 4% on an Android tablet.

Conclusion:  Both Google and Facebook advertising platforms were able to reach a large audience of potential study participants for a rare disease. Each platform collects its own type of user data and differs in how ads can be targeted. Overall, Facebook was cheaper per a click, led to more absolute clicks, and had a higher percentage of individuals who saw the ad click it.


Disclosure: A. Schiffenbauer, None; L. G. Rider, None; S. Faghihi-Kashani, None; K. Patel, None; F. W. Miller, None.

To cite this abstract in AMA style:

Schiffenbauer A, Rider LG, Faghihi-Kashani S, Patel K, Miller FW. The Effectiveness of Social Media in Recruiting for Rare Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-effectiveness-of-social-media-in-recruiting-for-rare-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effectiveness-of-social-media-in-recruiting-for-rare-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology